MMM
37
2
DIS
72
4
MAT
43
2
BF.B
35
2
PHM
48
2
ILMN
32
2
EXPE
88
2
KEY
27
3
D
35
2
BBY
52
4
NUE
41
2
KHC
15
4
NWS
75
6
APA
35
3
KIM
60
3
AMT
33
3
ICE
55
2
V
76
8
MAS
46
2
FTI
63
2
MMM
37
2
DIS
72
4
MAT
43
2
BF.B
35
2
PHM
48
2
ILMN
32
2
EXPE
88
2
KEY
27
3
D
35
2
BBY
52
4
NUE
41
2
KHC
15
4
NWS
75
6
APA
35
3
KIM
60
3
AMT
33
3
ICE
55
2
V
76
8
MAS
46
2
FTI
63
2
Financhill
Back

Malibu Boats 10K Form

Sell
19

MBUU
Malibu Boats

Last Price:
$36.83
Seasonality Move:
2.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MBUU News And Ratings

See the #1 stock for the next 7 days that we like better than MBUU

MBUU Financial Statistics

Sales & Book Value

Annual Sales: $829M
Cash Flow: $-17M
Price / Cash Flow: 14.81
Annual Sales: $26.04
Price / Book: 1.4

Profitability

EPS (TTM): -3.98000
Net Income (TTM): $-81.2M
Gross Margin: $147.1M
Return on Equity: -14.12%
Return on Assets: -9.91%

Malibu Boats Earnings Forecast

Key Malibu Boats Financial Ratios

  • The Gross Profit Margin over the past 14 years for MBUU is 17.74%.
  • The Selling, General & Administrative Expenses for MBUU have been equal to 11.95% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is -3.29% of Operating Income.
  • The Net Earning history of MBUU is -6.74% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 7 years.

Malibu Boats Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Leisure Products
Sector: Consumer Discretionary
Current Symbol: MBUU
CUSIP: 56117J
Website: malibuboats.com

Debt

Debt-to-Equity Ratio: 0.05
Current Ratio: 1.55
Quick Ratio: 0.44

Price-to-Earnings

Trailing P/E Ratio: 6.81
Forward P/E Ratio: 9.57

MBUU Technical Analysis vs Fundamental Analysis

Sell
19
Malibu Boats (MBUU) is a Sell

Is Malibu Boats a Buy or a Sell?

  • Malibu Boats stock is rated a Sell
    The current Malibu Boats [MBUU] share price is $36.82. The Score for MBUU is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.